
FLUOXETINE
Fluoxetine is a Selective Serotonin Reuptake Inhibitor (SSRI) used for treatment of Bulimia, Obsessive compulsive disorder, Panic reactions and Dysphoria. The assay is useful for monitoring serum concentrations, evaluation of potential toxicity and patient compliance.
-
Pre-test Information:
Ideal sampling time: >12 hours post oral dose.
-
Report Delivery:
Sample by 7th of the month; Report after 2–3 weeks
Related Products
-
TRIMIPRAMINE
0 out of 5Trimipramine is an antidepressant. Therapeutic drug monitoring is useful to optimize dose, evaluate potential toxicity and assess patient compliance.
-
Pre-test Information:
No special preparation required
-
Report Delivery:
Sample by 7th of the month; Report after 2–3 weeks
-
-
PHENCYCLIDINE (PCP), SCREEN, URINE
0 out of 5Phencyclidine (Angel dust) is a drug of abuse with stimulant, depressant, hallucinogenic and analgesic properties. It can be self administered by smoking, nasal insufflation, intravenous injection or oral ingestion.
-
Test Type:
Urine
-
Pre-test Information:
No special preparation required
-
Report Delivery:
Daily
-
-
DOXEPIN
0 out of 5Doxepin is recommended for the treatment of psychoneurotic patients with depression or anxiety specially associated with alcoholism or organic disease. The assay is useful in monitoring therapy, evaluating potential toxicity and patient compliance.
-
Pre-test Information:
Recommended specimen: >12 hours post oral dose.
-
Report Delivery:
Sample by 7th of the month; Report after 2–3 weeks
-
-
LAMOTRIGINE
0 out of 5Lamotrigine is used in the treatment of Bipolar I disorder and a wide variety of seizures including Primary generalized tonic clonic seizures and Partial seizures. It is also used to treat Migraine, Trigeminal neuralgia and Treatment refractory depression. This assay is used to monitor the blood levels, assess compliance and adjust dosage in patients receiving other anticonvulsant agents which interact pharmacokinetically with Lamotrigine.
-
Pre-test Information:
Recommended specimen: 0.5–1 hour before next dose at steady state
-
Report Delivery:
Sample by 7th of the month; Report after 2–3 weeks
-